Participation in advanced cancer clinical trials at Northwestern University
Official title: Northwestern University Lead Academic Participating Site
Funded at Northwestern University at Chicago · NIH-11249823 · Data updated 2026-11-12
This study is all about helping advanced cancer patients at Northwestern University find and join clinical trials that could offer them new treatment options and better care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | April 1, 2019 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $309,096 |
| NIH project number | 3UG1CA233320-06S1 |
| Project ID | NIH-11249823 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with advanced cancer who are seeking new treatment options through clinical trials.
✕Less likely to help
Patients with early-stage cancer or those not eligible for clinical trials may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing participation in clinical trials for advanced cancer patients at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The center has a strong history of involvement in national cancer trials and aims to improve patient outcomes through high-quality data collection and innovative cancer interventions. Patients may have the opportunity to participate in various clinical trials that explore new treatments and therapies for advanced malignancies. The research also emphasizes collaboration with multiple national cancer networks to ensure comprehensive care and support.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with advanced cancer.
How similar studies have gone: Previous research has shown success in improving patient outcomes through participation in similar advanced cancer clinical trials.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Benson, Al B — Northwestern University at Chicago
- Study coordinator: Benson, Al B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.